Find uplifting stories about heroes, innovations, and solutions
750 results for "lenacapavir injection"
South Africa just became the ninth African nation to offer lenacapavir, a breakthrough HIV drug that requires only two injections per year instead of daily pills. The treatment could transform care for millions living with HIV, though access and supply questions remain.
Kenya just received its first shipment of Lenacapavir, a groundbreaking HIV prevention treatment that requires just two injections per year instead of daily pills. The new option could dramatically reduce infections among pregnant and breastfeeding women, who face the highest risk.
Clinics across South Africa began rolling out lenacapavir this week, a groundbreaking HIV prevention injection that requires just two shots per year and is over 96% effective. Despite some staffing challenges, patients are celebrating easier access to life-changing protection.
South Africa just received its first shipment of Lenacapavir, a revolutionary HIV prevention injection that works for six months with a single dose. The breakthrough treatment could transform protection for vulnerable communities who struggle with daily prevention methods.
A new twice-yearly injection called lenacapavir prevents nearly all HIV infections and earned Science Magazine's 2024 Breakthrough of the Year. The discovery traces back to publicly funded research that started nearly 30 years ago.
A revolutionary HIV prevention shot that only requires two doses per year is coming to 271,000 people in Zimbabwe, backed by US support that could prevent more than 9,000 new infections. The groundbreaking injection removes daily pill barriers and offers a new path toward an AIDS-free generation.
Uganda is expanding access to a groundbreaking HIV prevention injection that only needs to be taken twice a year, offering nearly 100% protection. The innovation could transform HIV prevention for thousands who struggle with daily medication.
Kenya just became one of the first countries to offer a groundbreaking HIV prevention drug that requires just two injections per year, completely free to those who need it most. The move brings new hope to 1.4 million Kenyans living with HIV and vulnerable young people facing the highest risk of infection.
South Africa just became one of the first countries to roll out a revolutionary twice-yearly HIV prevention injection that could change the game for millions. After a decade of strategic planning, the nation is proving that bold public health leadership saves lives.
South Africa just became one of the first countries to offer a twice-yearly HIV prevention injection that could transform how the world fights the epidemic. The new treatment offers hope particularly for young women, who face the highest infection rates.
A twice-yearly HIV prevention shot is rolling out across Africa and beyond, replacing daily pills that half of users gave up within three months. South Africa began providing lenacapavir to at-risk groups in June 2024, backed by deals making it accessible in 120 countries. #
Nigeria just introduced a twice-yearly HIV injection that could replace daily pills and help eliminate AIDS within six years. The breakthrough treatment, called Lenacapavir, offers new hope for millions while reducing stigma and improving care access.
People living with HIV who struggle to take daily pills now have a breakthrough option: monthly injections that work twice as well at keeping the virus suppressed. A major study found this could transform care for thousands facing medication challenges.
South Africa just received its first shipment of a revolutionary HIV prevention medication that requires just two shots per year. In a country where 8.15 million people live with HIV, this could transform prevention efforts.
Kenya becomes the first country to roll out Lenacapavir, a groundbreaking injection that prevents HIV for six months with a single shot. The breakthrough could dramatically reduce the country's 20,000 annual new infections by eliminating daily pill routines.
A twice-yearly injection called Lenacapavir prevented HIV transmission with near-perfect results across two major trials involving 8,200 people in high-risk areas. The breakthrough could transform HIV prevention by replacing daily pills with just two shots per year.
South Africa just received 38,000 doses of a breakthrough HIV prevention injection that works for six months with just two shots per year. The country is the first in Africa to approve and roll out Lenacapavir, potentially transforming prevention for millions.
Scientists discovered that when HIV develops resistance to the groundbreaking drug lenacapavir, the virus loses its ability to spread effectively. This finding offers hope that the twice-yearly injection can remain a powerful tool in preventing and treating HIV.
Benue State, Nigeria's region with the highest HIV treatment burden, just introduced a groundbreaking injectable drug that requires only two doses per year instead of daily pills. The innovation could transform prevention for nearly 200,000 patients and vulnerable populations across the state. #
Kenya just became one of the first countries in the world to offer a revolutionary HIV prevention drug that only requires two shots per year. The free injectable could protect millions and dramatically reduce new infections across the nation.
Showing 20 of 750